Authors' Response to "Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: Discordance between the conclusion and the findings"

被引:0
|
作者
Abuelazm, Mohamed T. [1 ]
Abdelazeem, Basel [2 ,3 ]
Abd-elsalam, Sherief [1 ]
机构
[1] Tanta Univ, Fac Med, Tanta 3164420, Egypt
[2] McLaren Hlth Care, Flint, MI USA
[3] Michigan State Univ, E Lansing, MI 48824 USA
关键词
dual therapy; GRADE; lymphatic filariasis; triple therapy;
D O I
10.1111/tmi.13741
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:464 / 465
页数:2
相关论文
共 50 条
  • [1] Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: Discordance between conclusion and findings
    Cheema, Huzaifa Ahmad
    Shahid, Abia
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (04) : 463 - 463
  • [2] Efficacy and safety of triple therapy versus dual therapy for lymphatic filariasis: A systematic review and meta-analysis
    Abuelazm, Mohamed T.
    Abdelazeem, Basel
    Badr, Helmy
    Gamal, Mohamed
    Ashraf, Mohamed
    Abd-elsalam, Sherief
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2022, 27 (03) : 226 - 235
  • [3] THE EFFICACY OF TRIPLE DRUG THERAPY IN MASS DRUG ADMINISTRATION TO REDUCE LYMPHATIC FILARIASIS IN HAITI
    Hast, Marisa A.
    Dubray, Christine L.
    Sircar, Anita D.
    De Rochars, Madsen Beau
    Bogus, Joshua
    Direny, Abdel N.
    Ernest, Jean Romuald
    Fayette, Carl
    O'Brian, Katiuscia
    Goss, Charles W.
    Sabin, Daniel Frantz
    Wiegand, Ryan
    Lemoine, Jean Frantz
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 198 - 198
  • [4] Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Kirui, Elvis
    Oluka, Margaret
    Parthasarathi, Gurumurthy
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    [J]. DRUG SAFETY, 2023, 46 (10) : 961 - 974
  • [5] Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study
    Christabel Khaemba
    Abbie Barry
    Wyckliff P. Omondi
    Elvis Kirui
    Margaret Oluka
    Gurumurthy Parthasarathi
    Sammy M. Njenga
    Anastacia Guantai
    Eleni Aklillu
    [J]. Drug Safety, 2023, 46 : 961 - 974
  • [6] Efficacy and safety comparison of Helicobacter pylori eradication between vonoprazan dual therapy versus triple therapy: a systematic review and meta-analysis
    Wang, Zheyu
    Wang, Fen
    [J]. THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [7] Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Agarwal, Nayan
    Jain, Ankur
    Mahmoud, Ahmed N.
    Bishnoi, Rohit
    Golwala, Harsh
    Karimi, Ashkan
    Mojadidi, Mohammad Khalid
    Garg, Jalaj
    Gupta, Tanush
    Patel, Nimesh Kirit
    Wayangankar, Siddharth
    Anderson, R. David
    [J]. AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1280 - 1289
  • [8] Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin
    Amano, Hideo
    Saito, Daiga
    Yabe, Takayuki
    Okubo, Ryo
    Toda, Mikihito
    Ikeda, Takanori
    [J]. INTERNATIONAL HEART JOURNAL, 2017, 58 (04) : 570 - 576
  • [9] EFFICACY AND SAFETY OF JOSAMYCIN VERSUS CLARITHROMYCIN IN THE TRIPLE THERAPY COMBINED WITH BISMUTH
    Bordin, D. S.
    Yanova, O. B.
    Voynovan, I. N.
    Shaposhnikova, N. A.
    Orobey, Y. A.
    Berezina, O. I.
    Kovaleva, O. I.
    [J]. HELICOBACTER, 2015, 20 : 96 - 96
  • [10] One- or two-week triple therapy for Helicobacter pylori:: questions of efficacy and inclusion of a dual therapy treatment arm -: Authors' response
    Zagari, Rocco Maurizio
    Bazzoli, Franco
    [J]. GUT, 2007, 56 (07) : 1022 - 1023